Medical devices, healthcare technology and the business of care
510(k) clearance · K261647

Tempo Plating System; Ultra Compression Screw System

Pace Surgical · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK261647

What did the FDA decide?

FDA recorded a substantially equivalent decision (SESE) on September 3, 2026 for K261647, covering the Tempo Plating System and Ultra Compression Screw System from Pace Surgical. The submission sits under 21 CFR 888.3030 in Class II, orthopedic specialty, with product code HRS listed as primary and HWC also cited. Substantial equivalence is a 510(k) clearance, not premarket approval.

The record describes a plating system and a compression screw system, with plates indicated for bones of the toes, midfoot and hindfoot and non-locking screws indicated for reconstruction, osteotomy, arthrodesis, joint fusion and fracture repair and fixation. The summary lists K250952, K251555 and K203011 as predicate devices. The documents disagree on the received date, showing both August 5, 2026 and May 19, 2026, and the summary is dated September 1, 2026; the record does not resolve this. No clinical performance data are summarized here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261647
Regulatory pathway
510(k) premarket notification
Applicant
Pace Surgical
Product code
HRS
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Applicant
Pace Surgical
Product code
HRS
FDA device class
2

FDA decision timeline

  1. K261647 received

    Application receipt date recorded by FDA.

  2. K261647 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
ARTHREX, INC.510(k) clearanceOct 29, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceOct 23, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Pace Surgical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Malvern, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records